Sugi Predict

Sugi Predict / Compounds / SCHEMBL1189435

SCHEMBL1189435

SCHEMBL1189435

CCOC(=O)C(C)=C1CCC2(CC1)OCCO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ GABRP O00591 1/20 0.37
▸ GABRD O14764 1/20 0.37
▸ GABRA1 P14867 1/20 0.37
▸ GABRB1 P18505 1/20 0.37
▸ GABRG2 P18507 1/20 0.37
▸ GABRB3 P28472 1/20 0.37
▸ GABRA5 P31644 1/20 0.37
▸ GABRA3 P34903 1/20 0.37
▸ GABRA2 P47869 1/20 0.37
▸ GABRB2 P47870 1/20 0.37
▸ GABRA4 P48169 1/20 0.37
▸ GABRE P78334 1/20 0.37
▸ GABRA6 Q16445 1/20 0.37
▸ GABRG1 Q8N1C3 1/20 0.37
▸ GABRG3 Q99928 1/20 0.37
▸ GABRQ Q9UN88 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24454451 0.84 ALDH1A1 (0.41) ALDH1A1CYP3A4CYP2C19CYP2C9GABRP
SCHEMBL17443859 0.84 ALDH1A1 (0.41) ALDH1A1CYP3A4CYP2C19CYP2C9GABRP
SCHEMBL10149342 0.81 KMT2A (0.38) ALDH1A1CYP3A4CYP2C19CYP2C9POLB
SCHEMBL15862873 0.81 KMT2A (0.48) ALDH1A1CYP3A4CYP2C19CYP2C9KMT2A
SCHEMBL3879787 0.80 TSHR (0.42) ALDH1A1CYP3A4CYP2C19POLBKMT2A
SCHEMBL22270717 0.77 ALDH1A1 (0.40) ALDH1A1CYP3A4CYP2C19CYP2C9GABRP
SCHEMBL22387460 0.77 POLB (0.37) ALDH1A1CYP3A4CYP2C19CYP2C9POLB
SCHEMBL25547583 0.75 GLO1 (0.39) ALDH1A1KMT2AHPGDSMN1; SMN2LMNA
SCHEMBL7041913 0.75 GLO1 (0.39) ALDH1A1KMT2AHPGDSMN1; SMN2LMNA
SCHEMBL19095447 0.73 TSHR (0.36) ALDH1A1POLBKMT2AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11932601-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2024-03-19 — — US disclosed
US-20220305144-A1 RADIOLIGANDS FOR IMAGING THE ID01 ENZYME BRISTOL MYERS SQUIBB CO (US) 2022-09-29 — — US disclosed
US-20220274926-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES INC (US) 2022-09-01 — — US disclosed
US-11242319-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2022-02-08 — — US disclosed
US-11242319-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2022-02-08 — — US disclosed
EP-3854394-A1 IMMUNOREGULATORY AGENTS Flexus Biosciences, Inc. (US) 2021-07-28 — — EP disclosed
EP-3215142-B1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES INC (US) 2021-03-24 — — EP disclosed
EP-3215153-B1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES INC (US) 2020-12-23 — — EP disclosed
US-20190282714-A1 RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME BRISTOL MYERS SQUIBB CO (US) 2019-09-19 — — US disclosed
US-20190282714-A1 RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME BRISTOL MYERS SQUIBB CO (US) 2019-09-19 — — US disclosed
US-20160137652-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. 2016-05-19 — — US disclosed
US-20160137653-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. 2016-05-19 — — US disclosed
WO-2016073774-A2 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. (US) 2016-05-12 — — WO disclosed
WO-2016073738-A2 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. (US) 2016-05-12 — — WO disclosed
WO-2016073738-A2 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. (US) 2016-05-12 — — WO disclosed
WO-2016073770-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. (US) 2016-05-12 — — WO disclosed
US-8735425-B2 Tetrahydroisoquinoline derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-27 — — US disclosed
EP-2256105-B1 NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2013-12-04 — — EP disclosed
US-20110034481-A1 NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-02-10 — — US disclosed
EP-2256105-A1 NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2010-12-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11242319-B2 Immunoregulatory agents IDO1, IDO2, INMT ALDH1A1 219/4885CYP3A4 1482/4885CYP2C19 3094/4885
US-20160137653-A1 IMMUNOREGULATORY AGENTS IDO1, IDO2, INMT ALDH1A1 219/4885CYP3A4 1482/4885CYP2C19 3094/4885
US-20110034481-A1 NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE DGAT1, DGAT2, DLAT ALDH1A1 789/4885CYP3A4 2032/4885CYP2C19 3596/4885
US-20190282714-A1 RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME IDO1, IDO2, KYNU ALDH1A1 524/4885CYP3A4 374/4885CYP2C19 740/4885
US-20160137652-A1 IMMUNOREGULATORY AGENTS IDO1, IDO2, INMT ALDH1A1 219/4885CYP3A4 1482/4885CYP2C19 3094/4885
US-11932601-B2 Immunoregulatory agents IDO1, IDO2, INMT ALDH1A1 219/4885CYP3A4 1482/4885CYP2C19 3094/4885
US-20220274926-A1 IMMUNOREGULATORY AGENTS IDO1, IDO2, INMT ALDH1A1 219/4885CYP3A4 1482/4885CYP2C19 3094/4885
US-20220305144-A1 RADIOLIGANDS FOR IMAGING THE ID01 ENZYME IDO1, IDO2, IDUA ALDH1A1 274/4885CYP3A4 580/4885CYP2C19 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.